跳至主要内容
临床试验/NL-OMON55598
NL-OMON55598招募中不适用

A prospective study to assess the efficacy and safety of the BlueWind RENOVA iStim* System for the treatment of patients diagnosed with overactive bladder (OASIS - OverActive bladder StImulation System study) - BlueWind RENOVA iStim* System for the treatment of OAB

BlueWind Medical Ltd.0 个研究点目标入组 25 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 2 - Female aged 18 or greater (21 or greater in the US), with no plans to
  • become pregnant
  • during the trial; if of bearing potential, negative pregnancy test and
  • if sexually active, using
  • acceptable contraception.
  • 4 - Diagnosis of UUI demonstrated on a 7-consecutive days voiding diary
  • a minimum of nine (9) leaking episodes associated with urgency with at
  • least one episode per
  • day for 5 days.
  • 5 - More than or equal to 6 months history of UUI diagnosis
  • 6 - Patient with inadequate response to any of the following conservative
  • treatments (i.e.
  • dietary restriction, fluid restriction, bladder training, behavioral
  • modification, pelvic muscle
  • training, biofeedback, etc.) and pharmacologic treatment.

排除标准

  • 1 - Previous participation in another study with any investigational drug or
  • within the past 90 days
  • 5 - Any significant medical condition that is likely to interfere with study
  • procedures,
  • device operation, or likely to confound evaluation of study endpoints
  • 19 - More than minimal level of stress incontinence or mixed incontinence
  • with stress
  • component likely to confound study outcome, based on a 7-day voiding
  • diary or medical history,or when stress incontinence score in the MESA
  • incontinence questionnaire is higher than the urgency incontinence score
  • 28 - Have a life expectancy of less than 1 year

研究者

相似试验

A prospective study to assess the efficacy and... | 临床试验